Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1987 May;31(5):811–812. doi: 10.1128/aac.31.5.811

In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.

M Walsh, E W Kappus, T C Quinn
PMCID: PMC174839  PMID: 3038010

Abstract

The antimicrobial activity of CP-62,993 against four Chlamydia trachomatis isolates was compared with those of erythromycin, clindamycin, and tetracycline. The MIC of CP-62,993 was 0.26 to 1.02 micrograms/ml for 100% inclusion inhibition and 0.031 to 0.063 microgram/ml for 50% inclusion inhibition. With pharmacokinetic and antimicrobial studies demonstrating prolonged half-life and in vitro effectiveness, CP-62,993 may make possible a single, short-course treatment regimen for C. trachomatis infection.

Full text

PDF
811

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackman H. J., Yoneda C., Dawson C. R., Schachter J. Antibiotic susceptibility of Chlamydia trachomatis. Antimicrob Agents Chemother. 1977 Dec;12(6):673–677. doi: 10.1128/aac.12.6.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Mourad A., Sweet R. L., Sugg N., Schachter J. Relative resistance to erythromycin in Chlamydia trachomatis. Antimicrob Agents Chemother. 1980 Nov;18(5):696–698. doi: 10.1128/aac.18.5.696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ridgway G. L., Owen J. M., Oriel J. D. The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. Br J Vener Dis. 1978 Apr;54(2):103–106. doi: 10.1136/sti.54.2.103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Sanders L. L., Jr, Harrison H. R., Washington A. E. Treatment of sexually transmitted chlamydial infections. JAMA. 1986 Apr 4;255(13):1750–1756. [PubMed] [Google Scholar]
  5. Schachter J. Chlamydial infections (third of three parts). N Engl J Med. 1978 Mar 9;298(10):540–549. doi: 10.1056/NEJM197803092981005. [DOI] [PubMed] [Google Scholar]
  6. Stamm W. E., Tam M., Koester M., Cles L. Detection of Chlamydia trachomatis inclusions in Mccoy cell cultures with fluorescein-conjugated monoclonal antibodies. J Clin Microbiol. 1983 Apr;17(4):666–668. doi: 10.1128/jcm.17.4.666-668.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Thompson S. E., 3rd, Hager W. D., Wong K. H., Lopez B., Ramsey C., Allen S. D., Stargel M. D., Thornsberry C., Benigno B. B., Thompson J. D. The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients. Am J Obstet Gynecol. 1980 Jan 15;136(2):179–186. doi: 10.1016/0002-9378(80)90592-x. [DOI] [PubMed] [Google Scholar]
  8. Thompson S. E., Washington A. E. Epidemiology of sexually transmitted Chlamydia trachomatis infections. Epidemiol Rev. 1983;5:96–123. doi: 10.1093/oxfordjournals.epirev.a036266. [DOI] [PubMed] [Google Scholar]
  9. Yoder B. L., Stamm W. E., Koester C. M., Alexander E. R. Microtest procedure for isolation of Chlamydia trachomatis. J Clin Microbiol. 1981 Jun;13(6):1036–1039. doi: 10.1128/jcm.13.6.1036-1039.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES